Device Liquid Embolics For Interventional Radiology

Instylla Microcatheter

Payments companies reported to CMS as associated with Instylla Microcatheter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$210Kassociated payments (2023-2025)
67clinicians with associated payments
1company reporting

By year

2023 $80K
2024 $130K

Payments reported as associated with Instylla Microcatheter, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $175K
Diagnostic Ultrasound $25K
Diagnostic Radiology $6,680
Internal Medicine $1,287
Gastroenterology (Internal Medicine) $1,125
Pediatric Radiology $102

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Instylla Microcatheter

These are the largest totals companies reported as associated with Instylla Microcatheter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
David Tahour Long Beach, CA Vascular & Interventional Radiology $39,803.94
Kei Yamada Atlanta, GA Vascular & Interventional Radiology $34,929.98
Suvranu Ganguli Boston, MA Vascular & Interventional Radiology $27,002.21
Salomao Faintuch Boston, MA Diagnostic Ultrasound $25,142.48
Dimitry Rabkin Boston, MA Vascular & Interventional Radiology $21,317.48
Venkatesh Krishnasamy Birmingham, AL Vascular & Interventional Radiology $19,457.50
Eric Gandras Manhasset, NY Vascular & Interventional Radiology $6,529.36
Nadine Abi-Jaoudeh Orange, CA Vascular & Interventional Radiology $5,603.20
Edgar St Amour Little Rock, AR Vascular & Interventional Radiology $4,806.24
Thomas Dibartholomeo Shelton, CT Diagnostic Radiology $3,584.76

Prescribed Instylla Microcatheter?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.